Mielóma multiplex: vizsgálatok itt: Kína
204 trials · From ClinicalTrials.gov, checked 2026. november 17.. Ask the study team whether a trial fits you.
- Korai 1. fázisNot yet taking people in KínaA Study of Humanized BCMA-targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple Myeloma
- Where
- Hangzhou
- Életkor
- 30 év to 75 év
- People
- 50
- Run by
- Zhejiang University
See details and how to joinNCT04670055 - Korai 1. fázisNot yet taking people in KínaA Study of CS1-targeted CAR-T Cells Therapy for Relapsed Multiple Myeloma After BCMA CAR-T Cells Therapy
- Where
- Hangzhou
- Életkor
- 30 év to 75 év
- People
- 50
- Run by
- Zhejiang University
See details and how to joinNCT04541368 - 1/2. fázisTaking peopleComparation of Chidamide Plus VRD (Bortezomib, Lenalidomide, Dexamethasone) With VRD Regimen for Primary High-Risk Multiple Myeloma Patients
- Where
- Suzhou
- Életkor
- 18 év to 80 év
- People
- 50
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT04025450 - 1/2. fázisTaking peopleStudy of T Cells Targeting CD138/BCMA/CD19/More Antigens (CART-138/BCMA/19/More) for Chemotherapy Refractory and Relapsed Multiple Myeloma
- Where
- Suzhou
- Életkor
- 18 év to 75 év
- People
- 10
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT03196414